Hyaluronidase: Its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00179906%3A_____%2F13%3A10146026" target="_blank" >RIV/00179906:_____/13:10146026 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/13:10146026 RIV/60162694:G44__/13:43874788
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S0378427413001689" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0378427413001689</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.toxlet.2013.04.013" target="_blank" >10.1016/j.toxlet.2013.04.013</a>
Alternative languages
Result language
angličtina
Original language name
Hyaluronidase: Its effects on HI-6 dichloride and dimethanesulphonate pharmacokinetic profile in pigs
Original language description
Pigs were administered intramuscularly molar equivalents of HI-6 salts (HI-6 dichloride 10.71 mg/kg and HI-6 DMS 13.59 mg/kg) either with or without hyaluronidase (60 U/kg). Hyaluronidase is supposed to increase tissue permeability and diminishes discomfort caused by the intramuscular injection. Doses of HI-6 salts corresponded with standard HI-6 dichloride dose in one autoinjector (500 mg) and were recalculated for 1 kg of body weight. According to the results, both HI-6 salts applied in combination with hyaluronidase had increased tissue absorption and improved pharmacokinetic profile. The Cmax was significantly higher in case of HI-6 DMS plus hyaluronidase (29.6 +- 2.98 ?g/ml) administration increase compared to HI-6 DMS (23.8 +- 3.04 ?g/ml) and HI-6 dichloride (19.0 +- 0.93 ?g/ml); both without hyaluronidase. Bioavailability calculated as AUCtotal (HI-6 DMS with hyaluronidase, 4119 +- 647 min ?g/ml) was also significantly higher compared to HI-6 DMS (2259 +- 329 min ?g/ml) and HI-6
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT12062" target="_blank" >NT12062: Preparation and biological evaluation of new therapeutics against to pesticides</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Toxicology Letters
ISSN
0378-4274
e-ISSN
—
Volume of the periodical
220
Issue of the periodical within the volume
2
Country of publishing house
IE - IRELAND
Number of pages
5
Pages from-to
167-171
UT code for WoS article
000320595100009
EID of the result in the Scopus database
—